Trials / Completed
CompletedNCT00546728
The Vascular Effects of Exenatide Versus Metformin in Patients With Pre-Diabetes
The Chronic and Acute Postprandial Vascular Effects of Exenatide vs. Metformin in Abdominally Obese Patients With Impaired Glucose Tolerance
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- St. Paul Heart Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the effects of exenatide versus metformin on vascular health with chronic (3-month) therapy and during a 2-hour period following a meal in patients with pre-diabetes. It is predicted that exenatide will improve vascular health to a greater degree compared to metformin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Exenatide | exenatide 10 mcg twice daily |
| DRUG | Metformin | metformin 500 twice daily |
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2011-07-01
- Completion
- 2011-07-01
- First posted
- 2007-10-19
- Last updated
- 2013-11-08
- Results posted
- 2013-11-08
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00546728. Inclusion in this directory is not an endorsement.